Sildenafil
Product Images NDC 68788-7379

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68788-7379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Tablets 1

A Kaplan-Meier survival curve chart depicting estimated cumulative mortality rate percentages over time in years for three groups described as High Dose, Medium Dose, and Low Dose. The y-axis shows estimated cumulative mortality rate (%) from 0 to 25%, and the x-axis shows time from 0 to 5 years. The chart includes the number of individuals at risk at yearly intervals for each dose group.*

FDA Label Image

Sildenafil Tablets 2

Chemical structure of the active ingredient Sildenafil, as shown in the labeled diagram with molecular groups and bonds depicted.*

FDA Label Image

Sildenafil Tablets 3

A chart showing fold changes and 90% confidence intervals in AUC and Cmax of various interacting drugs relative to Sildenafil alone, with recommendations on dose adjustments. Drugs listed include Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir.*

FDA Label Image

Sildenafil Tablets 4

A forest plot chart showing fold changes and 90% confidence intervals for various interacting drugs with sildenafil, including acenocoumarol, aspirin, atorvastatin, bosentan, doxazosin (three doses), ethinylestradiol, levonorgestrel, phenprocoumon, ritonavir, saquinavir, and tolbutamide. The x-axis represents change relative to the interacting drug alone, and recommendations on dose adjustment are noted, mostly indicating no dose adjustment needed except for ritonavir coadministration which is not recommended.*

FDA Label Image

Sildenafil Tablets 5

A line plot showing change from baseline (in meters) over study weeks (Week 4, Week 8, Week 12) for groups receiving Sildenafil at doses of 20 mg, 40 mg, and 80 mg taken three times daily (TID) compared to placebo. The graph includes error bars and plots the time points with distinct markers for each group.*

FDA Label Image

Sildenafil Tablets 6

A forest plot depicting placebo-corrected changes in 6-minute walk distance comparing sildenafil 20 mg TID versus placebo across various patient subgroups. Variables include baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index. Each subgroup’s effect size is shown with confidence intervals.*

FDA Label Image

Sildenafil Tablets 7

Label for Sildenafil Tablets 20 mg, generic for Revatio, from Preferred Pharmaceuticals Inc. It states each tablet contains Sildenafil Citrate equivalent to 20 mg Sildenafil. The label includes directions in English and Spanish and a caution about federal law prohibiting drug transfer. Manufacturer is Actavis Pharma, Inc. Storage instructions and warnings are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.